Effects of Oxygen Radical Scavengers on the Inactivation of SS ΦX174 DNA by the Semi-Quinone Free Radical of the Antitumor Agent Etoposide

References

• Issell B. F., Rudolph A. R., Louie A. C. Etoposide (VP-16–213): an overview. Etoposide (VP-16), current status and new developments, B F. Issell, F M. Muggia, S K. Carter. Academic Press, New York 1984; 6–8
   Google Scholar
• Van Maanen J. M.S., Retèl J., de Vries J., Pinedo H. M. Mechanism of action of antitumor drug etoposide: a review. J. Nat. Cancer Inst. 1988; 80: 1526–1533
   PubMed Web of Science ®Google Scholar
• Glisson B. S., Smallwood S. E., Ross W. E. Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cells. Biochim. Biophys. Acta 1984; 783: 74–79
   PubMed Web of Science ®Google Scholar
• Ross W., Rowe T., Glisson B., Yalowich J., Liu L. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res. 1984; 44: 5857–5860
   PubMed Web of Science ®Google Scholar
• Chen G. L., Yang L., Rowe T. C., Halligan B. D., Tewey K. M., Liu L. F. Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem. 1984; 259: 13560–13566
   PubMed Web of Science ®Google Scholar
• Minocha A., Long B. H. Inhibition of the DNA catenation activity of type II topoisomerase by VP16–213 and VM26. Biochem. Biophys. Res. Commun. 1984; 122: 165–170
   PubMed Web of Science ®Google Scholar
• Loike J. D., Horwitz S. B. Effect of VP-16–213 on the intracellular degradation of DNA in HeLa cells. Biochemistry 1976; 15: 5443–5448
   PubMed Web of Science ®Google Scholar
• Long B. H., Musial S. F., Brattain M. G. Comparison of cytotoxicity and DNA breakage-activity of congeners of podophyllotoxin including VP 16–213 and VM 26: a quantitative structure-activity relationship. Biochemistry 1984; 23: 1183–1188
   PubMed Web of Science ®Google Scholar
• Van Maanen J. M.S., de Ruiter C., de Vries J., Kootstra P. R., Gobas F., Pinedo H. M. The role of metabolic activation by cytochrome P-450 in covalent binding of VP-16–213 to rat liver and HeLa cell microsomal proteins. Eur. J. Cancer Clin. Oncol. 1985; 21: 1099–1106
   PubMedGoogle Scholar
• Van Maanen J. M.S., van den Akker E., de Vries J., Bakkenist A. R.J., Lankelma J., Retèl J., Pinedo H. M. Structure-bioactivation relationship of a series of podophyllotoxin derivatives. Eur. J. Cancer Clin. Oncol. 1988; 24: 1415–1419
   PubMedGoogle Scholar
• Van Maanen J. M.S., de Vries J., Pappie D., van den Akker E., Lafleur M. V.M., Retèl J., van der Greef J., Pinedo H. M. Cytochrome P-450-mediated O-demethylation: a route in the metabolic activation of etoposide (VP-16–213). Cancer Res. 1987; 47: 4658–4662
   PubMed Web of Science ®Google Scholar
• Sinha B. K., Trush M. A., Kalyanaraman B. Microsomal interactions and inhibition of lipid peroxidation by etoposide (VP-16–213): implications for mode of action. Biochem. Pharmacol. 1985; 34: 2036–2040
   PubMedGoogle Scholar
• Haim N., Nemec J., Roman J., Sinha B. K. In vitro metabolism of etoposide (VP-16–213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins. Biochem. Pharmacol. 1987; 36: 527–536
   PubMed Web of Science ®Google Scholar
• Van Maanen J. M.S., Lafleur M. V.M., Mans D. R.A., van den Akker E., de Ruiter C., Kootstra P. R., Pappie D., de Vries J., Retèl J., Pinedo H. M. Effects of the ortho-quinone and catechol of the antitumor drug VP-16–213 on the biological activity of single-stranded and double-stranded 0X174 DNA. Biochem. Pharmacol. 1988; 37: 3579–3589
   PubMedGoogle Scholar
• Haim N., Roman J., Nemec J., Sinha B. K. Peroxidative free radical formation and O-demethylation of etoposide (VP-16) and teniposide (VM-26). Biochem. Biophvs. Res. Commun. 1986; 135: 215–220
   PubMed Web of Science ®Google Scholar
• Van Maanen J. M.S., de Ruiter C., Kootstra P. R., Lafleur M. V.M., de Vries J., Retèl J., Pinedo H. M. Inactivation of ΦX174 DNA by the ortho-quinone derivative or its reduction product of the antitumor agent VP-16–213. Eur, J. Cancer Clin. Oncol. 1985; 21: 1215–1218
   PubMedGoogle Scholar
• Van Maanen J. M.S., Verkerk U. H., Broersen J., Lafleur M. V.M., deVries J., Retèl J., Pinedo H. M. Semi-quinone formation from the catechol and ortho-quinone metabolites of the antitumor agent VP-16–213. Free Rad. Res. Comms. 1988; 4: 371–384
   PubMed Web of Science ®Google Scholar
• D'Incalci M., Garattini S. Podophyllotoxin derivatives VP-16 and VM-26. Cancer Chemotherapy and Biological Response Modifiers Annual, H. M. Pinedo, D. L. Longo, B. A. Chabner. Elsevier Science Publ. B.V. 1988; 10: 59, Chapter 7
   Google Scholar
• Kalyanaraman B., Nemec J., Sinha B. K. Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR study. Biochemistry 1989; 28: 4839–4846
   PubMed Web of Science ®Google Scholar
• Mans D. R.A., van Maanen J. MS, Lafleur M. V.M., van Schaik M. A., Retèl J., Lankelma J. Role of the semi-quinone free radical of VP-16–213 in the inactivation of single-stranded (ss) ΦX174 DNA. Proc. Am. Assoc. Cancer Res. 1989; 30: 489
   Google Scholar
• Powis G. Metabolism and reactions ofquinoid anticancer agents. Pharmac. Ther. 1987; 35: 57–162
   PubMed Web of Science ®Google Scholar
• Holthuis J. J.M., van Oort W. J., Römkens F. M.G.M., Renema J., Zuman P. Electrochemistry of podophyllotoxin derivatives. I. Oxidation mechanism of etoposide (VP-16–213). J. Electroanal. Chem. 1985; 184: 317–329
   Google Scholar
• Blok J., Luthjens L. H., Roos A. L.M. The radiosensitivity of bacteriophage DNA in aqueous solution. Radiat. Res. 1967; 30: 468–482
   PubMed Web of Science ®Google Scholar
• Klein S. M., Cohen G., Cederbaum A. I. The interaction of hydroxyl radicals with dimethylsulfoxide produces formaldehyde. Febs Letters 1980; 116: 220–222
   PubMedGoogle Scholar
• Van Rijn K., Mayer T., Blok J., Verberne J. B., Loman H. Reaction rate of OH radicals with 0X174 DNA: influence of salt and scavenger. Int. J. Radiat. Biol. 1985; 47: 309–317
   Web of Science ®Google Scholar
• Mans D. R.A., Retèl J., van Maanen J. MS, Lafleur M. V.M., van Schaik M. A., Pinedo H. M., Lankelma J. Role of the semi-quinone free radical of the antitumor agent VP-16–213 (etoposide) in the inactivation of single- and double-stranded ΦX174 DNA, Manuscript in preparation
   Google Scholar
• Lai C., Piette L. H. Hydroxyl radical production involved in lipid peroxidation of rat liver microsomes. Biochem. Biophys. Res. Commun. 1977; 78: 51–59
   PubMed Web of Science ®Google Scholar
• Finkelstein E., Rosen G. M., Rauckman E. J. Spin trapping of superoxide and hydroxyl radical: practical aspects. Arch. Biochem. Biophys. 1980; 200: 1–16
   PubMed Web of Science ®Google Scholar
• Gutierrez P. L., Fox B. M., Mossoba M. M., Bachur N. R. Free radicals in quinone-containing antitumor agents. Mol. Pharmacol. 1984; 26: 582–586
   PubMed Web of Science ®Google Scholar
• Finkelstein E., Rosen G. M., Rauckman E. J., Paxton J. Spin trapping of superoxide. Mol. Pharmacol. 1979; 16: 676–685
   PubMed Web of Science ®Google Scholar
• Lesko S. A., Lorentzen R. J., Ts'o P. O.P. Role of superoxide in deoxyribonucleic acid strand scission. Biochemistry 1980; 19: 3023–3028
   PubMed Web of Science ®Google Scholar
• Wozniak A. J., Glisson B. S., Hande K. R., Ross W. E. Inhibition of etoposide-induced DNA damage and cytotoxicity in L1210 cells by dehydrogenase inhibitors and other agents. Cancer Res. 1984; 44: 626–632
   PubMed Web of Science ®Google Scholar